Autoimmune Diseases  >>  edratide (hCDR1)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
edratide (hCDR1) / XTL Biopharma
PRELUDE, NCT00203151 / 2005-001391-12: A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Terminated
2
340
US, Canada, Europe, RoW
edratide
Teva Branded Pharmaceutical Products R&D, Inc.
Systemic Lupus Erythematosus
02/07
02/07

Download Options